Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix. Paterniti TA, Dorr K, Ullah A, White J, et al. Obstet Gynecol 2021;138:813-816.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Paterniti TA, Dorr K, Ullah A, White J, et al. Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix. Obstet Gynecol 2021;138:813-816.
PMID: 34619736